Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Incannex HealthcareIXHL -5.45%32 Quick Ratio is 41.56 as of Mar. 2026, which is 999% above its 10-year median of 3.78. GuruFocus rates IXHL with a GF Score™ of 32/100. The stock has 2 warning signs investors should review. Among 998 Drug Manufacturers companies, Incannex Healthcare ranks better than 99.4% on this metric.
Incannex Healthcare has a quick ratio of 41.56. It generally indicates good short-term financial strength.
The historical rank and industry rank for Incannex Healthcare's Quick Ratio or its related term are showing as below:
IXHL'
s Quick Ratio Range Over the Past 10 Years
Min: 0.25 Med: 3.78 Max: 48.27
Current: 41.56
During the past 13 years, Incannex Healthcare's highest Quick Ratio was 48.27. The lowest was 0.25. And the median was 3.78.
IXHL's Quick Ratio is ranked better than 99.4% of 998
companies
in the Drug Manufacturers industry
Industry Median: 1.45
vs IXHL: 41.56
Incannex Healthcare (NAS:IXHL) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Incannex Healthcare Quick Ratio Related Terms
Incannex Healthcare Quick Ratio Historical Data
* Premium members only.
The historical data trend for Incannex Healthcare's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Incannex Healthcare's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Incannex Healthcare Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Incannex Healthcare's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Incannex Healthcare's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Incannex Healthcare's Quick Ratio for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Incannex Healthcare (IXHL) has a Quick Ratio of 41.56 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Incannex Healthcare and its competitors. This is 999% above median its historical median of 3.78. Over the past decade, Incannex Healthcare's Quick Ratio has ranged from 0.25 to 48.27. According to the industry distribution chart, Incannex Healthcare ranks #6 out of 998 companies in the Drug Manufacturers industry, placing it in the top 0.59999999999999%.
Is Incannex Healthcare's Quick Ratio too high?
Incannex Healthcare's current Quick Ratio of 41.56 is 999% above median its 10-year median of 3.78. Over the past 10 years, this metric has ranged from a low of 0.25 to a high of 48.27. The Drug Manufacturers industry median Quick Ratio is 1.45. Incannex Healthcare's value of 41.56 is 2766.2% above this industry median. Based on the distribution chart, Incannex Healthcare ranks #6 out of 998 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Incannex Healthcare has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Incannex Healthcare's Quick Ratio compare to BTAI and SCYX?
According to the Drug Manufacturers industry distribution chart, Incannex Healthcare ranks #6 out of 998 companies for Quick Ratio. This places Incannex Healthcare in the top 1% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.45. Incannex Healthcare's value of 41.56 is 2766.2% above this benchmark. Historically, Incannex Healthcare's own Quick Ratio has ranged from 0.25 to 48.27 over the past decade. While the company's 10-year median is 3.78 vs. the industry median of 1.45, Incannex Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 998 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Incannex Healthcare's current Quick Ratio of 41.56 is 2766.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Incannex Healthcare and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Incannex Healthcare's current Quick Ratio is 41.56, which is 999% above median its own 10-year median of 3.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Incannex Healthcare stock overvalued right now?
Incannex Healthcare (IXHL) has a current Quick Ratio of 41.56. The current Quick Ratio is 41.56, which is 999% above median its 10-year median of 3.78 and 2766.2% above the Drug Manufacturers industry median of 1.45. Incannex Healthcare's overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Incannex Healthcare (IXHL), the current Quick Ratio is 41.56 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
32GF Score
Get the complete analysis for IXHL
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IXHL has been successfully added to your 
